Valbiotis SA (EPA:ALVAL)

Valbiotis Statistics

Total Valuation

Valbiotis has a market cap or net worth of EUR 25.31 million. The enterprise value is 21.73 million.

Market Cap	25.31M
Enterprise Value	21.73M

Important Dates

The next estimated earnings date is Friday, June 26, 2026.

Earnings Date	Jun 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Valbiotis has 23.66 million shares outstanding. The number of shares has increased by 25.53% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	+25.53%
Shares Change (QoQ)	+49.54%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	3.43%
Float	22.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.97
PB Ratio	3.64
P/TBV Ratio	4.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.31
EV / Sales	24.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.70

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.73.

Current Ratio	2.85
Quick Ratio	2.22
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	-0.63
Interest Coverage	-60.86

Financial Efficiency

Return on equity (ROE) is -108.68% and return on invested capital (ROIC) is -42.18%.

Return on Equity (ROE)	-108.68%
Return on Assets (ROA)	-34.91%
Return on Invested Capital (ROIC)	-42.18%
Return on Capital Employed (ROCE)	-93.04%
Weighted Average Cost of Capital (WACC)	3.00%
Revenue Per Employee	18,100
Profits Per Employee	-188,340
Employee Count	50
Asset Turnover	0.05
Inventory Turnover	0.91

Taxes

In the past 12 months, Valbiotis has paid 2,000 in taxes.

Income Tax	2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.19% in the last 52 weeks. The beta is -0.21, so Valbiotis's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-0.19%
50-Day Moving Average	1.02
200-Day Moving Average	0.83
Relative Strength Index (RSI)	55.66
Average Volume (20 Days)	154,270

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Valbiotis had revenue of EUR 905,000 and -9.42 million in losses. Loss per share was -0.47.

Revenue	905,000
Gross Profit	-1.17M
Operating Income	-9.49M
Pretax Income	-9.42M
Net Income	-9.42M
EBITDA	-9.20M
EBIT	-9.49M
Loss Per Share	-0.47

Balance Sheet

The company has 8.68 million in cash and 5.09 million in debt, with a net cash position of 3.59 million or 0.15 per share.

Cash & Cash Equivalents	8.68M
Total Debt	5.09M
Net Cash	3.59M
Net Cash Per Share	0.15
Equity (Book Value)	6.96M
Book Value Per Share	0.29
Working Capital	7.73M

Cash Flow

In the last 12 months, operating cash flow was -8.04 million and capital expenditures -8,000, giving a free cash flow of -8.05 million.

Operating Cash Flow	-8.04M
Capital Expenditures	-8,000
Depreciation & Amortization	296,000
Net Borrowing	-484,000
Free Cash Flow	-8.05M
FCF Per Share	-0.34

Margins

Gross Margin	-128.84%
Operating Margin	-1,049.06%
Pretax Margin	-1,040.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Valbiotis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.53%
Shareholder Yield	-25.53%
Earnings Yield	-37.20%
FCF Yield	-31.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Valbiotis has an Altman Z-Score of -1.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.06
Piotroski F-Score	3